Skip to main content
Clinical Trials/NCT03654950
NCT03654950
Completed
Not Applicable

PEPP - Patient Empowerment With the Patient Perspective

Sahlgrenska University Hospital, Sweden1 site in 1 country200 target enrollmentJune 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Sahlgrenska University Hospital, Sweden
Enrollment
200
Locations
1
Primary Endpoint
Patient reported experiences in themes
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The overall aim with this study is to gain a deeper understanding of patient perceptions regarding empowerment in relation to a health platform.

Detailed Description

This is a two-stage study design. The first stage consists of focus groups interviews. Three focus groups with 6-8 patients (colorectal cancer patients diagnosed at least one year ago) in each group, will be invited. The focus group interviews will be moderated by one researcher, but accompanied with a second observing researcher. The participants will be identified using the regional Swedish ColoRectal Cancer Registry in Västra Götaland. The participants will be contacted by a short letter (appendix) indicating that we will call them with more information. The participants will by phone be asked to participate in the study and then invited to the focus groups. The second phase of the project includes a questionnaire, which will be sent to 200 patients from the same population. The questionnaires will be delivered by using the Sunet Survey system, which is a system approved by University of Gothenburg. If the participants prefers a paper copy, or lack the possibility to reply online, a paper copy will be send via mail instead. At this moment the investigators have developed a questionnaire, which may be refined due to the understating achieved from the focus group interviews.

Registry
clinicaltrials.gov
Start Date
June 1, 2018
End Date
December 1, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Sahlgrenska University Hospital, Sweden
Responsible Party
Principal Investigator
Principal Investigator

Eva Angenete

Associate professor, consultant surgeon

Sahlgrenska University Hospital, Sweden

Eligibility Criteria

Inclusion Criteria

  • Patient with colorectal cancer

Exclusion Criteria

  • Inability to give informed consent or speaking and reading the Swedish language.

Outcomes

Primary Outcomes

Patient reported experiences in themes

Time Frame: 1 day

interview

Secondary Outcomes

  • Patient reported experiences divided into themes(12 months)

Study Sites (1)

Loading locations...

Similar Trials